Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 22, Issue 12, Pages 1475-1481
Publisher
Springer Nature
Online
2016-11-15
DOI
10.1038/nm.4211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Landscape of post-transcriptional gene regulation during hepatitis C virus infection
- (2015) Johannes Schwerk et al. Current Opinion in Virology
- Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness
- (2014) Timothy Sheahan et al. Cell Host & Microbe
- New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
- (2014) Jean–Michel Pawlotsky GASTROENTEROLOGY
- A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
- (2014) Andrew J. Muir et al. JOURNAL OF HEPATOLOGY
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating Hepatitis C in Lower-Income Countries
- (2014) Channa R. Jayasekera et al. NEW ENGLAND JOURNAL OF MEDICINE
- HCV Infection Selectively Impairs Type I but Not Type III IFN Signaling
- (2013) Partha K. Chandra et al. AMERICAN JOURNAL OF PATHOLOGY
- HCV direct-acting antiviral agents: the best interferon-free combinations
- (2013) Raymond Schinazi et al. LIVER INTERNATIONAL
- A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
- (2013) Ludmila Prokunina-Olsson et al. NATURE GENETICS
- The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus–induced microRNAs
- (2013) Adelle P McFarland et al. NATURE IMMUNOLOGY
- Novel therapies for hepatitis C — one pill fits all?
- (2013) Michael P. Manns et al. NATURE REVIEWS DRUG DISCOVERY
- Current and Future Therapies for Hepatitis C Virus Infection
- (2013) T. Jake Liang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care
- (2012) Brian L Pearlman LANCET INFECTIOUS DISEASES
- Deciphering the Interleukin 28B Variants That Better Predict Response to Pegylated Interferon-α and Ribavirin Therapy in HCV/HIV-1 Coinfected Patients
- (2012) Montserrat de Castellarnau et al. PLoS One
- Analysis of IL28B Variants in an Egyptian Population Defines the 20 Kilobases Minimal Region Involved in Spontaneous Clearance of Hepatitis C Virus
- (2012) Vincent Pedergnana et al. PLoS One
- Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance
- (2011) Julia di Iulio et al. HEPATOLOGY
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- 1360 PEGYLATED INTERFERON-LAMBDA (PEGIFN-λ) SHOWS SUPERIOR VIRAL RESPONSE WITH IMPROVED SAFETY AND TOLERABILITY VERSUS PEGIFNα-2A IN HCV PATIENTS (Gl/2/3/4): EMERGE PHASE IIB THROUGH WEEK 12
- (2011) S. Zeuzem et al. JOURNAL OF HEPATOLOGY
- Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase
- (2010) Shuanghu Liu et al. ANTIVIRAL RESEARCH
- Evolving epidemiology of hepatitis C virus
- (2010) D. Lavanchy CLINICAL MICROBIOLOGY AND INFECTION
- Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
- (2010) Masao Honda et al. GASTROENTEROLOGY
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
- (2010) Andri Rauch et al. GASTROENTEROLOGY
- Virus-Induced Unfolded Protein Response Attenuates Antiviral Defenses via Phosphorylation-Dependent Degradation of the Type I Interferon Receptor
- (2009) Jianghuai Liu et al. Cell Host & Microbe
- A Family of microRNAs Encoded by Myosin Genes Governs Myosin Expression and Muscle Performance
- (2009) Eva van Rooij et al. DEVELOPMENTAL CELL
- Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial
- (2009) Tania Mara Welzel et al. HEPATOLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- (2009) David L. Thomas et al. NATURE
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started